nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS1—kidney cancer	0.58	0.636	CbGaD
Lornoxicam—PTGS2—kidney cancer	0.332	0.364	CbGaD
Lornoxicam—CYP2C9—Capecitabine—kidney cancer	0.0188	0.458	CbGbCtD
Lornoxicam—CYP2C9—Paclitaxel—kidney cancer	0.0118	0.287	CbGbCtD
Lornoxicam—CYP2C9—Sorafenib—kidney cancer	0.0104	0.255	CbGbCtD
Lornoxicam—Tenoxicam—PTGS1—kidney cancer	0.00203	0.273	CrCbGaD
Lornoxicam—Meloxicam—PTGS1—kidney cancer	0.00145	0.195	CrCbGaD
Lornoxicam—Piroxicam—PTGS1—kidney cancer	0.00126	0.169	CrCbGaD
Lornoxicam—Tenoxicam—PTGS2—kidney cancer	0.00116	0.156	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—kidney cancer	0.000828	0.111	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—kidney cancer	0.000718	0.0964	CrCbGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—kidney cancer	0.000184	0.00461	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—SOD2—kidney cancer	0.000183	0.00459	CbGpPWpGaD
Lornoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—kidney cancer	0.000179	0.00449	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTT1—kidney cancer	0.000168	0.0042	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—ANXA1—kidney cancer	0.000166	0.00414	CbGpPWpGaD
Lornoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000162	0.00405	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000156	0.0039	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—kidney cancer	0.000154	0.00386	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—GSTM1—kidney cancer	0.000151	0.00377	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	0.00015	0.00376	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000149	0.00372	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000149	0.00372	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—SOD2—kidney cancer	0.000146	0.00364	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000143	0.00358	CbGpPWpGaD
Lornoxicam—PTGS1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000142	0.00356	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.000142	0.00356	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.000141	0.00354	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000141	0.00352	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—EGR1—kidney cancer	0.000139	0.00348	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000139	0.00347	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.00013	0.00326	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000124	0.0031	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000123	0.00307	CbGpPWpGaD
Lornoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000122	0.00306	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—kidney cancer	0.000119	0.00298	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTP1—kidney cancer	0.000116	0.00291	CbGpPWpGaD
Lornoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—kidney cancer	0.000116	0.0029	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000113	0.00282	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—KIT—kidney cancer	0.000112	0.0028	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00011	0.00276	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	0.000108	0.00271	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—GSTM1—kidney cancer	0.000107	0.00268	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—RELA—kidney cancer	0.000106	0.00265	CbGpPWpGaD
Lornoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000103	0.00258	CbGpPWpGaD
Lornoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—kidney cancer	0.000102	0.00255	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—CYP1A1—kidney cancer	0.000101	0.00254	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000101	0.00253	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000101	0.00253	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.0001	0.00251	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	9.96e-05	0.00249	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	9.75e-05	0.00244	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	9.46e-05	0.00237	CbGpPWpGaD
Lornoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.23e-05	0.00231	CbGpPWpGaD
Lornoxicam—PTGS2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	9.2e-05	0.0023	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—kidney cancer	9.08e-05	0.00227	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACY1—kidney cancer	8.92e-05	0.00223	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTT1—kidney cancer	8.83e-05	0.00221	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	8.55e-05	0.00214	CbGpPWpGaD
Lornoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	8.52e-05	0.00213	CbGpPWpGaD
Lornoxicam—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	8.42e-05	0.00211	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	8.3e-05	0.00208	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—PTGS1—kidney cancer	8.27e-05	0.00207	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	8.23e-05	0.00206	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	8.04e-05	0.00201	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	8.04e-05	0.00201	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	7.67e-05	0.00192	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.6e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PDHB—kidney cancer	7.58e-05	0.0019	CbGpPWpGaD
Lornoxicam—PTGS1—Biological oxidations—POMC—kidney cancer	7.56e-05	0.00189	CbGpPWpGaD
Lornoxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.48e-05	0.00187	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.3e-05	0.00183	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CCBL1—kidney cancer	7.13e-05	0.00178	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACY1—kidney cancer	7.08e-05	0.00177	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CCBL1—kidney cancer	6.76e-05	0.00169	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.45e-05	0.00161	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GLIPR1—kidney cancer	6.18e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPAT—kidney cancer	6.18e-05	0.00155	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	6.15e-05	0.00154	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	6.13e-05	0.00153	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTP1—kidney cancer	6.12e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AMER1—kidney cancer	6.11e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.1e-05	0.00153	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	6.04e-05	0.00151	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	6.03e-05	0.00151	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PDHB—kidney cancer	6.02e-05	0.00151	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL2—kidney cancer	6e-05	0.0015	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	5.85e-05	0.00146	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.8e-05	0.00145	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APRT—kidney cancer	5.75e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—FH—kidney cancer	5.75e-05	0.00144	CbGpPWpGaD
Lornoxicam—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	5.69e-05	0.00142	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CCBL1—kidney cancer	5.66e-05	0.00142	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—GSTM1—kidney cancer	5.62e-05	0.00141	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.62e-05	0.00141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	5.54e-05	0.00139	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPC3—kidney cancer	5.4e-05	0.00135	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	5.33e-05	0.00133	CbGpPWpGaD
Lornoxicam—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	5.26e-05	0.00132	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CA2—kidney cancer	5.26e-05	0.00131	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALAD—kidney cancer	5.12e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GPC3—kidney cancer	5.12e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.12e-05	0.00128	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ST3GAL2—kidney cancer	5e-05	0.00125	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GLIPR1—kidney cancer	4.91e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPAT—kidney cancer	4.91e-05	0.00123	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALDH1A1—kidney cancer	4.89e-05	0.00122	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.84e-05	0.00121	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	4.82e-05	0.00121	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.8e-05	0.0012	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ST3GAL2—kidney cancer	4.74e-05	0.00119	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MYC—kidney cancer	4.69e-05	0.00117	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACY1—kidney cancer	4.69e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PGK1—kidney cancer	4.68e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC5A3—kidney cancer	4.68e-05	0.00117	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LDHB—kidney cancer	4.59e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	4.59e-05	0.00115	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APRT—kidney cancer	4.56e-05	0.00114	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—FH—kidney cancer	4.56e-05	0.00114	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.55e-05	0.00114	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.5e-05	0.00113	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.46e-05	0.00112	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC5A3—kidney cancer	4.44e-05	0.00111	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PGK1—kidney cancer	4.44e-05	0.00111	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SFRP2—kidney cancer	4.35e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LDHB—kidney cancer	4.35e-05	0.00109	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPC3—kidney cancer	4.29e-05	0.00107	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CA2—kidney cancer	4.17e-05	0.00104	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	4.17e-05	0.00104	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALAD—kidney cancer	4.07e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCEB2—kidney cancer	4.06e-05	0.00102	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCEB1—kidney cancer	4.06e-05	0.00102	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4e-05	0.001	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PDHB—kidney cancer	3.99e-05	0.000997	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CA9—kidney cancer	3.98e-05	0.000997	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.98e-05	0.000995	CbGpPWpGaD
Lornoxicam—CYP2C9—Biological oxidations—POMC—kidney cancer	3.97e-05	0.000994	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ST3GAL2—kidney cancer	3.97e-05	0.000993	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.97e-05	0.000993	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.94e-05	0.000985	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.89e-05	0.000974	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALDH1A1—kidney cancer	3.88e-05	0.00097	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—TP53—kidney cancer	3.85e-05	0.000963	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.84e-05	0.00096	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CCBL1—kidney cancer	3.75e-05	0.000938	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PGK1—kidney cancer	3.72e-05	0.00093	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC5A3—kidney cancer	3.72e-05	0.00093	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LDHB—kidney cancer	3.65e-05	0.000912	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.47e-05	0.000867	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.39e-05	0.000848	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CRABP1—kidney cancer	3.39e-05	0.000847	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPL14—kidney cancer	3.3e-05	0.000826	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.28e-05	0.000821	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.25e-05	0.000813	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPAT—kidney cancer	3.25e-05	0.000813	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.21e-05	0.000803	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.19e-05	0.000798	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.18e-05	0.000795	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CA9—kidney cancer	3.16e-05	0.000791	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ITPR2—kidney cancer	3.15e-05	0.000788	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.12e-05	0.000781	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.09e-05	0.000773	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APRT—kidney cancer	3.02e-05	0.000756	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FH—kidney cancer	3.02e-05	0.000756	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ITPR2—kidney cancer	2.98e-05	0.000747	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.95e-05	0.000739	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.95e-05	0.000737	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.9e-05	0.000726	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTT1—kidney cancer	2.87e-05	0.000718	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ACHE—kidney cancer	2.87e-05	0.000718	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPC3—kidney cancer	2.84e-05	0.000711	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA2—kidney cancer	2.76e-05	0.000691	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SCARB1—kidney cancer	2.72e-05	0.00068	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.71e-05	0.000677	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALAD—kidney cancer	2.69e-05	0.000674	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CRABP1—kidney cancer	2.69e-05	0.000673	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PSMD7—kidney cancer	2.64e-05	0.00066	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.63e-05	0.000658	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.62e-05	0.000655	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.57e-05	0.000643	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—BCHE—kidney cancer	2.5e-05	0.000626	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PSMD7—kidney cancer	2.5e-05	0.000626	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ITPR2—kidney cancer	2.5e-05	0.000625	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC5A5—kidney cancer	2.47e-05	0.000618	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PGK1—kidney cancer	2.46e-05	0.000616	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.46e-05	0.000616	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LDHB—kidney cancer	2.41e-05	0.000604	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A1—kidney cancer	2.39e-05	0.000597	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.31e-05	0.000579	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.3e-05	0.000576	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—kidney cancer	2.28e-05	0.00057	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACHE—kidney cancer	2.28e-05	0.00057	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A1—kidney cancer	2.26e-05	0.000566	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JUNB—kidney cancer	2.25e-05	0.000562	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SCARB1—kidney cancer	2.16e-05	0.00054	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTGS1—kidney cancer	2.14e-05	0.000534	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PSMD7—kidney cancer	2.09e-05	0.000524	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA9—kidney cancer	2.09e-05	0.000524	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.05e-05	0.000512	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.02e-05	0.000505	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—kidney cancer	1.99e-05	0.000498	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—BCHE—kidney cancer	1.99e-05	0.000497	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC5A5—kidney cancer	1.96e-05	0.000491	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A1—kidney cancer	1.89e-05	0.000474	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCB1—kidney cancer	1.88e-05	0.000471	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—kidney cancer	1.83e-05	0.000458	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN2B—kidney cancer	1.83e-05	0.000457	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CRABP1—kidney cancer	1.78e-05	0.000445	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1A1—kidney cancer	1.73e-05	0.000434	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ITPR2—kidney cancer	1.66e-05	0.000414	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.6e-05	0.000401	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—kidney cancer	1.58e-05	0.000395	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.53e-05	0.000382	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—kidney cancer	1.51e-05	0.000378	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACHE—kidney cancer	1.51e-05	0.000378	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCB1—kidney cancer	1.5e-05	0.000374	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIF1A—kidney cancer	1.46e-05	0.000366	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TSC2—kidney cancer	1.46e-05	0.000365	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—kidney cancer	1.45e-05	0.000363	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SCARB1—kidney cancer	1.43e-05	0.000357	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.42e-05	0.000356	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS1—kidney cancer	1.41e-05	0.000354	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PSMD7—kidney cancer	1.39e-05	0.000347	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1A1—kidney cancer	1.38e-05	0.000344	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—BCHE—kidney cancer	1.31e-05	0.000329	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.3e-05	0.000325	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—POMC—kidney cancer	1.29e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APC—kidney cancer	1.29e-05	0.000322	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KIT—kidney cancer	1.29e-05	0.000322	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.25e-05	0.000314	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.22e-05	0.000304	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BRAF—kidney cancer	1.21e-05	0.000303	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.13e-05	0.000283	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.06e-05	0.000266	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—kidney cancer	1.05e-05	0.000262	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—kidney cancer	1.03e-05	0.000258	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—POMC—kidney cancer	1.03e-05	0.000257	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RAF1—kidney cancer	1.01e-05	0.000253	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB2—kidney cancer	9.99e-06	0.00025	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCB1—kidney cancer	9.9e-06	0.000248	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTOR—kidney cancer	9.86e-06	0.000247	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD4—kidney cancer	9.84e-06	0.000246	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—kidney cancer	9.61e-06	0.000241	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1B—kidney cancer	9.26e-06	0.000232	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.11e-06	0.000228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—kidney cancer	8.99e-06	0.000225	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CTNNB1—kidney cancer	8.74e-06	0.000219	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—kidney cancer	8.52e-06	0.000213	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.49e-06	0.000187	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAPK3—kidney cancer	7.28e-06	0.000182	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—kidney cancer	7.14e-06	0.000179	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—kidney cancer	7.08e-06	0.000177	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAPK1—kidney cancer	6.93e-06	0.000173	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—POMC—kidney cancer	6.79e-06	0.00017	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—kidney cancer	6.54e-06	0.000164	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CA—kidney cancer	6.34e-06	0.000159	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CA—kidney cancer	6.01e-06	0.00015	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—kidney cancer	5.42e-06	0.000136	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CA—kidney cancer	5.04e-06	0.000126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—kidney cancer	4.73e-06	0.000118	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.33e-06	8.34e-05	CbGpPWpGaD
